These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2581595)

  • 1. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
    de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
    Bone; 1985; 6(1):15-20. PubMed ID: 2581595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat.
    Felsenfeld AJ; Machado L; Rodriguez M
    J Am Soc Nephrol; 1991 Jan; 1(7):970-9. PubMed ID: 1883967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone histomorphometry in hemodialysed patients.
    de Vernejoul MC; Kuntz D; Miravet L; Gueris J; Bielakoff J; Ryckewaert A
    Metab Bone Dis Relat Res; 1981; 3(3):175-9. PubMed ID: 7347793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluoride on aluminum-induced bone disease in rats with renal failure.
    Ittel TH; Gruber E; Heinrichs A; Handt S; Hofstädter F; Sieberth HG
    Kidney Int; 1992 May; 41(5):1340-8. PubMed ID: 1614048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.
    Faugere MC; Malluche HH
    Kidney Int; 1986 Nov; 30(5):717-22. PubMed ID: 2431192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis.
    Nilsson P; Melsen F; Malmaeus J; Danielson BG; Mosekilde L
    Bone; 1985; 6(1):21-7. PubMed ID: 2581596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic aluminum osteomalacia: identification of patients at risk.
    Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M
    Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical demonstration of iron but not aluminum in a case of dialysis-associated osteomalacia.
    Phelps KR; Vigorita VJ; Bansal M; Einhorn TA
    Am J Med; 1988 Apr; 84(4):775-80. PubMed ID: 3041812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model of aluminum-induced osteomalacia: role of chronic renal failure.
    Robertson JA; Felsenfeld AJ; Haygood CC; Wilson P; Clarke C; Llach F
    Kidney Int; 1983 Feb; 23(2):327-35. PubMed ID: 6842959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and reversibility of aluminum-induced bone lesion in the rat.
    Ott SM; Feist E; Andress DL; Liu CC; Sherrard DJ; Alfrey AC; Slatopolsky E; Howard GA
    J Lab Clin Med; 1987 Jan; 109(1):40-7. PubMed ID: 3794513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.